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T lymphocytes play a critical role in a cell-mediated immune response. During 
activation, extracellular and intracellular signals alter T cell metabolism in order to 
meet the energetic and biometabolic needs of a proliferating, active cell, but control of 
these phenomena is not well defined.  The idea that metabolism can be regulated 
directly via receptor-mediated signals is being investigated.  The T cell receptor 
(TCR) and CD28 pathways were stimulated and signaling was modified using 
chemical inhibitors of MAP kinases.  Metabolic changes were monitored using assays 
for glucose uptake, hexokinase activity, glycolysis, Krebs Cycle, and pentose 
phosphate pathway.  Two MAPK pathways (ERK, JNK) appear to be determining 
factors because their inhibition downregulated metabolism.  Inhibition of another 
MAPK pathway (p38) causes some downregulation of these activities but the effect is 
not as strong as with the ERK and JNK inhibitors, suggesting that the p38 pathway is 
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T lymphocytes play a critical role in a cell-mediated immune response. During 
activation, extracellular and intracellular signals alter T cell metabolism in order to 
meet the energetic and biometabolic needs of a proliferating, active cell, but cellular 
control of these phenomena is not well defined. Previous theories suggested increased 
metabolite use and subsequent catabolic derepression allowed metabolism to perform 
at maximum levels, without regulation, and that increased metabolism was simply an 
end result of signaling.  An alternative idea - that metabolism can be regulated directly 
via receptor-mediated signals - is being investigated. To define the role of 
carbohydrate flux in T cell activation, the T cell receptor (TCR) and CD28 pathways 
were stimulated using antibody-coated beads. At 24 hours, metabolic changes induced 
by these signals were monitored using assays for glucose uptake, hexokinase activity, 
glycolysis, Krebs Cycle, and pentose phosphate pathway.  Results showed that 
activated T cells dramatically raised glucose flux through GLUT1, hexokinase, and 
glycolysis and pentose phosphate pathway, but not Krebs Cycle. Then, signaling 
through the TCR and CD28 pathways was modified using chemical inhibitors of MAP 
kinases. Metabolic changes induced by these altered signals were monitored. Two 
MAPK pathways (ERK, JNK) appear to be determining factors because their 
inhibition downregulated glucose uptake, hexokinase activity, glycolysis and Krebs 
Cycle. Inhibition of another MAPK pathway (p38) causes some downregulation of 
these activities but the effect is not as strong as with the ERK and JNK inhibitors, 
suggesting that the p38 pathway is less important in regulating glucose metabolism. It 




other nutrients may still feed through it.  These phenomena could have clinical 







T cells play an important role in immune responses by detecting antigens presented on 
cell surfaces and coordinating the actions and fates of other cells.  T cells show 
dramatic changes in cellular activity upon stimulation, including a need for increased 
metabolism.  Changes in nutrient availability and metabolism within T cells may have 
a greater influence on the outcome of an activation event than previously thought.  
Current studies on T cell activation are revisiting metabolic analyses performed in the 
last century, but now the focus is on integration of the metabolic signal with other 
signaling pathways in order to construct a more holistic model of T cell activation and 
anergy induction.  The emerging paradigm is one where metabolism plays as 
significant a role as conventional signaling does in modulating and directing the cell's 
immune response [Fig. 1].  The idea now is that increased metabolism is not merely 
an afterthought in response to increased energetic and biosynthetic needs, but could 
instead be a mechanism to sense the availability of nutrients, provide feedback to the 
cell that will allow and enhance activation, and push the cell to channel glucose into 
biosynthetic products rather than energy production alone. 
 
Resting lymphocytes depend upon growth signals from cytokines and low-level TCR 
stimulation in order to maintain homeostasis, and they don't upregulate expression of 
glucose transporters or change their metabolism or activation state in response to high 
levels of extracellular glucose (Rathmell et al. 2000; Rathmell et al. 2001).  Glucose 
metabolism in resting T cells is split equally between lactate production (glycolysis), 















Figure 1. Paradigms of the role and regulation of metabolism during T cell activation.  
Previous ideas held that the cell responds to a stimulation signal  by increasing its 
uptake and metabolism.  The proposed paradigm holds that the cell monitors both 
outside signals as well as available nutrients before it commits to activation.  The 












phosphate pathway), and synthetic reactions (glycosylation reactions), while lactate 
production predominates in activated cells (Hume et al. 1978).  These findings 
indicate that activation doesn't result in a straightforward upregulation of all metabolic 
pathways, and that simply having an abundance of glucose does not mean a cell will 
become activated; there must be some signal or combination of signals in addition to 
nutrient availability that changes the rate and fate of glucose carbon flux.   
 
Lymphocyte activation leads to regulation of a change in metabolic state, but what the 
instructive signals are, and which cell components they change, are not well 
understood.  Glucose metabolism in concanavalin A-activated T cells is skewed 
toward lactate production.  In resting cells, 28% of glucose use can be traced to 
energy production and 38% to lactate production.  In activated cells, the values are 
20% and 58%, respectively (Hume et al. 1978).  There are several different 
hypotheses why this altered state of metabolism in lymphocytes, termed aerobic 
glycolysis, happens.  A switch to aerobic glycolysis could enable the cell to produce 
more energy while keeping electron transport chain activity, and thus free radical 
production, to a minimum (Brand and Hermfisse 1997).  It could be a mechanism that 
allows the cell to shunt glucose toward anabolism rather than energy production.  It 
could be an adaptation that allows T cells to become activated in a low-oxygen 
environment or it could be a correlate to the finding that oxygen can inhibit 





The change from resting to activated T cell begins with a signal through the T cell 
receptor (TCR).  When the TCR is stimulated, signal transduction pathways are 
activated and transcription of gene products is enhanced.  What those gene products 
will be is determined by concomitant signaling both within and from outside the cell.  
When signaling through only the TCR occurs, the cell enters a state called anergy 
which is characterized by an inability to respond to an antigen that would normally 
elicit an immune response.  When signaling through the TCR occurs along with 
costimulation through CD28, the cell becomes activated and participates in an 
immune response.  Some research has been done to determine how glucose fits into 
this activation model, and this thesis presents some questions and details some 
experiments which will help define the role of glucose in the immune response of 
lymphocytes. 
 
The results derived from this thesis will be important not only in T cell research but in 
other areas of metabolism and lymphocyte research as well because B cells also 
upregulate glucose metabolism upon receptor stimulation (Doughty et al. 2006).  It is 
important to study glucose metabolism in T cells to determine how it affects their 
function.  It is meaningful to study metabolism in T cells because this knowledge can 
be incorporated into a broader model of general cell metabolism.  Lymphocytes are a 
better model than more metabolically specialized cells like hepatocytes and 
adipocytes which primarily transport glucose in an insulin-dependent manner.  Also, 
the metabolic difference between active and resting T cells is relatively large, which 





The long term goal of the proposed study is to increase understanding of what 
happens to the metabolism of lymphocytes during the time when they transform from 
resting to activated.  Immunotherapies such as allergy injections, immunizations, and 
administration of IL-2 and other cytokines rely on providing an external signal to 
lymphocytes.  The effects of glucose metabolism on cells could also be exploited in 
order to fine tune the complex mix of signals received by cells in order to achieve the 



























Glucose does not easily diffuse through membranes but must instead be transported 
across via a member of the hexose transporter family, so called because they transport 
the six-carbon sugars fructose, galactose and glucose.  Through molecular cloning, a 
family of integral membrane glycoproteins containing at least 12 glucose transporter 
(GLUT) genes has been identified (Joost et al. 2002), many of which have high 
homology between mice and humans - Glut1 from mice and its human homologue 
SCL2A1 are 96% similar.  Most cells express more than one hexose transporter, and 
all are transmembrane proteins with 12 transmembrane domains, cytoplasmic C- and 
N-termini, an extracellular glycosylated loop between TM1-TM2, and an intracellular 
loop between TM6-TM7.  Most glucose transporters work by facilitated diffusion; 
hexose transport is achieved by a series of conformational changes that move the 
hexose across the cell membrane from a binding site on one side to a binding site on 
the other side, the relative binding affinities of which differ.  ATP is not used, though 
SGLUT1 and SGLUT5 are sodium-glucose symporters (Zhao et al. 2005).  Some 
GLUTs can also catalyze the movement of glucose out of the cell by reversing the 
conformational changes that transported it in if the intracellular glucose concentration 
is high. 
 
Glucose transporter 1 (GLUT1), the primary transporter found on lymphocytes 




generally considered the ubiquitous vertebrate glucose transporter.  It is also the cell 
surface receptor for Human T Cell Leukemia Virus (HTLV), and it can be blocked by 
HTLV-1 and -2 receptor-binding domains of the envelope glycoproteins (Manel et al. 
2003).  It can also be inhibited by cytochalasin B, dehydroascorbic acid (Agus et al. 
1997), and a less specific inhibitor - phloretin (Chung et al. 2002).  Its Michaelis-
Menton constant (Km) is 1-1.5mM which is slightly lower than the average blood 
glucose concentration of 4 - 8mM, so GLUT1 is saturated at physiological blood 
glucose levels, and glucose enters most cells at a fairly slow and steady pace through 
this transporter. 
 
GLUT1 and GLUT3 (glucose/galactose) are similar, and are found in most cells.  
GLUT2 (glucose/galactose/fructose) is found in pancreatic beta cells and liver cells, 
and it transports glucose much more quickly than GLUT1.  GLUT4 (glucose) is found 
in skeletal and cardiac muscle cells, as well as in adipocytes and hepatocytes, and 
surface expression of GLUT4 is upregulated by insulin receptor activation.  GLUT5 
(fructose) and SGLUT5 (glucose/galactose/sodium) are found on intestinal 
epithelium.  The homeostatic effect of the various transporters is that cells take up 
glucose at a steady rate from the blood via the slower GLUTs, and when the 
concentration of glucose increases after a meal, GLUT4 reacts quickly to sequester 
the glucose into specialized cells. 
Hexokinase 
Hexokinase phosphorylates glucose into glucose-6-phosphate and allows it to enter a 




glycolysis.  It can catalyze the magnesium-dependent and ATP-dependent conversion 
of D-fructose, 5-keto-D-fructose, D-glucose, 2-deoxy-D-glucose, D-mannose and D-
glucosamine to their respective hexose-6-phosphate forms.  This phosphorylation 
transforms the glucose into an anion, trapping it in the cell because large anions 
cannot cross cell membranes and because cells do not have membrane transport 
systems for phosphorylated sugars.  This conversion changes glucose from a 
biologically inert molecule into a reactive one that can enter metabolic pathways, and 
it also removes glucose from equilibrium which allows the cell to maintain a 
favorable concentration gradient.  Mitochondrially-bound hexokinase has been shown 
to be the driving force for the “Warburg Effect” - extremely high glycolytic activity – 
that takes place aerobically in tumor cells and other activated cells (Bustamante and 
Pedersen, 1977).  Hexokinase requires magnesium ions for its catalytic activity.  It is 
activated by catecholamines and related compounds (Harrison et al. 1972). Calcium 




Glucose may enter the metabolism of the cell via glycolysis or via the pentose 
phosphate pathway (PPP), both of which take place in the cytoplasm.  Glycolysis is 
the process whereby glucose is broken down into pyruvate [Fig. 2] which may then 
enter the Krebs Cycle, be metabolized into lactic acid and excreted, or enter other 
metabolic pathways.  Each step of glycolysis either releases a small, capturable 






Figure 2. Glycolysis.  This metabolic process uses enzymes to degrade glucose to 
pyruvate, creating ATP and recharging NADH.  The first step, creation of glucose-6-
phosphate, is mediated by hexokinase which is one of the enzymes whose activity is 
reported in this thesis.  Production of water during the eighth reaction mediated by 




energy may be captured during subsequent steps.  All steps take place anaerobically, 
and this is the primary pathway a eukaryotic cell uses for energy production if there is 
no oxygen available. Glycolysis begins when glucose is phosphorylated into glucose-
6-phosphate by hexokinase + ATP.    The third step of glycolysis is the step that 
commits glucose to glycolysis: once phosphofructokinase, an allosterically regulated 
enzyme controlled by several inhibitors and activators, phosphorylates fructose-6-
phosphate, the reverse reaction does not readily proceed spontaneously because of the 
high free energy requirement in the reverse direction (delta G 0' = +5.4kcal/mol).  
This is also the rate-limiting step of conversion of glucose to pyruvate. 
 
Aerobic Glycolysis 
Aerobic glycolysis is the term used to identify upregulated glycolysis in the presence 
of oxygen without a corresponding consumption of oxygen.  It is characterized by 
high glycolytic activity even in the presence of oxygen (contrary to the Pasteur effect), 
and inhibition of oxidative phosphorylation by high levels of exogenous glucose 
(Rodríguez-Enríquez et al. 2001).  It has been shown that stimulation of lymphocytes 
with the plant lectin concanavalin A causes a proliferative response during which 
aerobic glycolysis occurs (Hume et al. 1978).  Bauer et al. (2004) have shown a 
similar, dose-dependent hematopoietic stem cell response to the addition of IL-3 in an 
IL-3-dependent cell line. 
 
Aerobic glycolysis may have a several-pronged influence on the cell.  First, 




inhibition of cyclin B-cdk1 activity that is caused by SET protein.  When cell lines are 
transfected with a GAPDH expression vector, the number of mitoses increase and cell 
cycle progression accelerates (Carujo et al. 2006).  Thus, upregulation of glycolysis 
may help to induce cell proliferation by this method.  Second, upregulation of 
glycolysis and concomitant downregulation of the Krebs Cycle may lower the amount 
of NADH and FADH2 produced while keeping ATP production at a sufficient level to 
ensure cell growth.  In this way, cells will have sufficient energy without excess 
production of free radicals made during electron transport chain synthesis of ATP at a 
time when delicate DNA is replicating in anticipation of cell cycle initiation (Brand 
and Hermfisse 1997).  Third, it is thought that the major function of aerobic glycolysis 
is to maintain sufficient amounts of glycolytic intermediates to act as precursors for 
macromolecule synthesis during a time when the cell is rapidly turning-over old 
molecules and synthesizing new ones.  Aerobic glycolysis is not simply a response to 
the need for ATP; inhibition of glycolysis in the presence of alternative Krebs Cycle 
metabolites blocks PHA-induced proliferation (Roos and Loos 1973).  It is not known 
whether the effects of glycolysis upregulation are a direct or indirect cause of mitosis, 
but it is important to recognize the concurrence of these events because it adds support 
to the hypothesis that T cell activation (of which proliferation is a part) and 
metabolism work synergistically. 
 
Krebs Cycle 
Krebs Cycle oxidizes acetyl CoA into CO2, phosphorylating energy (GTP), and 






Figure 3. Krebs Cycle.  This metabolic process rearranges the carbon backbone of 
pyruvate into various metabolites, releases CO2 and recharges NADH, FADH2 and 
GTP.  Carbon from glucose gets rearranged and recycled through this pathway, and 








reducing energy may be used to generate ATP via oxidative phosphorylation in the 
electron transport chain (ETC) of molecules embedded in the mitochondrial christae.  
Byproducts of ATP generation by the ETC include free radicals which may damage 
DNA, so the advantage of extracting maximum ATP by instructing glucose 
metabolites to pass through the Krebs Cycle may be offset by the deleterious effects 
of the free radicals on DNA and protein synthesis in a blasting T cell.  Therefore, 
Krebs Cycle may be an important chain of events for a growing and differentiating T 
cell to control.  Also, the metabolites of the Krebs Cycle are not constrained to the 
Cycle, but may be used as raw materials in many other pathways in the cell.  One 
advantage to this is that the cell, by controlling the amount of particular Krebs Cycle 
proteins, may regulate which metabolites are in abundance at any one time so that the 
cell may shunt metabolites to other metabolic pathways in a more direct and useful 
manner.   
 
Pentose Phosphate Pathway 
The pentose phosphate pathway is crucial to growing and proliferating cells - in 
rapidly proliferating hybridoma cells, >90% of glucose enters the pentose phosphate 
pathway (Bonarius et al. 2000).  Glucose-6-phosphate enters the PPP, the process 
whereby the carbon skeleton of glucose is used to synthesize the pentose sugar ribose-
5-phosphate.  A byproduct of this pathway is the phosphorylated sugar fructose-6-
phosphate [Fig. 4].  In performing these reactions, the PPP also recharges a reducing 
equivalent by converting NADP
+
 to NADPH.  Ribose-5-phosphate and NADPH are 






Figure 4.  Pentose Phosphate Pathway.  This metabolic process converts glucose-6-
phosphate to fructose-6-phosphate, ribose-5-phosphate and other biometabolite 
products while recharging NADPH and releasing CO2.  The two main functions of 
this pathway are to provide the cell with reducing energy, in the form of NADPH, 
which can be used as energy to drive biosynthesis or as reducing energy to protect the 
cell from free radicals, and to create 4- and 5-carbon sugars which are precursors to 







nucleic acids while fructose-6-phosphate is a substrate in the glycolytic pathway, and 
NADPH is used for reducing power (an electron source) in anabolic reactions such as 
fatty acid and steroid biosynthesis, as well as in conversion of ribonucleotides to 
deoxyribonucleotides.  In contrast, the NAD
+
 used in glycolysis primarily functions as 
an electron acceptor for oxidative, catabolic reactions.  PPP enzymes are found in 
high levels in liver, adipose, adrenal cortex, testicular, and lactating mammary gland 
tissues.  In fact, 30% of oxidation in the liver is due to the PPP.  There are two phases 
to the PPP, oxidative and nonoxidative.  The reaction performed by glucose-6-
phosphate dehydrogenase (G6PD) is the rate-limiting step in the PPP, as well as the 
step that commits glucose-6-phosphate to the PPP.   
 
Properties of T Cell Activation 
Activation can be induced by TCR stimulation and CD28 costimulation, concanavalin 
A, phytohaemagglutinin (PHA), and treatment with other mitogenic lectins.  PHA 
activation can be inhibited by using 2-deoxyglucose (2-DOG) (Roos and Loos 1973).  
2-DOG is a glucose analog that can be phosphorylated and trapped in the cell but 
cannot enter metabolism, and it kinetically inhibits the activity of 
phosphofructokinase, so being able to block activation with 2-DOG shows that 
glucose metabolism is a critical component of the process that leads to activation. 
 
The hallmarks of T cell activation are proliferation and IL-2 production, but there are 
numerous ways to confirm activation in an experimental setting, such as by testing for 




morphology changes can also be quickly assessed to determine if in-vitro activation 
has been successful and further experiments can be run.  During T cell activation, 
lactic acid is produced in excess and is excreted out of the cell.  In vivo, the lactic acid 
is pumped into the blood and transported to the liver for further metabolism.  In vitro, 
cells are typically cultured at ~pH7.2, and an increase in extracellular acidity can be 
detected with many commercial tissue culture media that contain phenol red, which 
turns from red to yellow at a pH of about 6.8.  A direct assay for lactic acid can be 
done, but simply looking at the media color can reveal a successful activation.  
Activation causes upregulation of several surface markers like CD25 and CD44 that 
can be detected with fluorescent antibodies.  Surface marker assays are an ideal check 
to determine if activation was successful because they can be run quickly and few 
cells are needed.   
 
T Cell Activation Signals 
Recognition of MHC/peptide by a TCR begins a cascade of signal transduction within 
the cell that ends by activating a set of transcription factors which regulate expression 
of various genes.  Depending on the amounts and types of costimulation given during 
the period of TCR engagement, cells may become anergic or activated (Alegre et al. 
2001).  When the TCR and its associated molecules (ζ-chains, CD3δ, -ε and -γ) and 
its accessory molecule (CD4 or -8), productively interact with an MHC/peptide 
complex, a cSMAC (central SupraMolecular Activation Cluster) is formed on the 
lipid raft with a pSMAC (peripheral SupraMolecular Activation Cluster) around it 




complexes are the beginning of a series of events that lead to clustering and 
scaffolding of immune activation molecules. 
 
Once anchor SMAC is formed, signaling molecules are in place to become activated.  
The SRC family kinase LCK, associated with CD4 or -8, phosphorylates tyrosine 
residues in the ITAMS of the TCR-ζ and CD3 molecules.  ZAP70 now associates at 
the ITAMs via its SH2 domains and is itself phosphorylated.  Two adapter proteins, 
LAT and SLP76, are phosphorylated by ZAP70, and they in turn recruit PLC gamma.  
Activated PLC cleaves the membrane lipid PIP2 into IP3 and DAG.  IP3 increases 
intracellular Ca
2+
 by releasing stores from the endoplasmic reticulum, which causes 
opening of cell membrane Ca
2+
 channels.  Ca
2+
 activates calcineurin, a ser/thr 
phosphatase, which cleaves several phosphates from the transcription factor NFAT.  
NFAT then translocates to the nucleus.  DAG combines with Ca
2+
 to activate the 
ser/thr kinase PKC which activates CARMA1, bringing TAK1 and IKK into close 
proximity and allowing TAK1 to phosphorylate IKK.  IKK adds two phosphates to 
IKB which marks it for degradation by the ubiquitin pathway.  Once freed from IKB, 
the transcription factor NFκB is allowed to translocate to the nucleus.  SLP76 also 
activates the guanine nucleotide exchange factors SOS and VAV which then initiate 
the MAP kinase cascades SOS → ERK and VAV → JNK.  ERK and JNK translocate 
to the nucleus where they phosphorylate, respectively, the transcription factors ELK 





It has been shown that although upregulation of biosynthesis can be sustained over the 
short term, extracellular signals are necessary to sustain this upregulation in order to 
transform a resting cell into a productive, activated lymphocyte.  One of these 
extracellular signals is activation of the costimulatory molecule CD28 by either B7.1 
(CD80) or B7.2 (CD86), both members of the B7 family of ligands (Sharpe and 
Freeman 2002).  There have been studies connecting immunoreceptor signaling to 
metabolic control: it has been shown that the CD28 activation pathway has some 
components in common with the insulin receptor/Glut4 activation pathway, notably 
AKT, which stimulates glucose transport and glycolysis (Parry et al. 1997) and 
promotes resistance to cell death-by-neglect (Rathmell et al. 2003), though the 
specific targets of AKT integral to T cell activation have not been defined (Frauwirth 
and Thompson 2004).  Other systems have shown that upregulated levels of AKT are 
associated with increased expression and cell surface localization of Glut1 (Rathmell 
et al. 2003) and that AKT is involved in the insulin/Glut4 and Glut1 regulation of 
glucose metabolism (Hernandez and Lorenzo 2001). 
 
Metabolic Control and Lymphocyte Function 
In microorganisms, the presence of extracellular nutrients results in cell growth and 
proliferation, but in metazoans, cell growth and proliferation are controlled by 
external signals.  Metabolism of lymphocytes is limited by trophic signals, low-level 
growth signals from cytokines or surface molecules on other cells, not nutrient 
availability.  Without extracellular signals, T cells reduce glucose import to levels 




Phosphoinositide-3-kinase (PI3K) and Protein kinase B (AKT) activity, both mediated 
by signaling receptors, are necessary for upregulation of glucose metabolism.  PI3K 
activates AKT, but in the absence of PI3K activity, constitutively active AKT will 
cause upregulation of glucose metabolism (Frauwirth et al. 2002).  Metabolism can, in 
turn, control activation state.  Glucose deprivation inhibits high production of IFNγ, a 
trait of CD8
+
 effector T cells, but not IL-2 production, a trait of both undifferentiated 
and effector cells (Cham and Gajewski 2005).  Blockade of glycolysis with 2-
deoxyglucose inhibits PHA-mediated activation (Roos and Loos 1973).  Lymphocytes 
deprived of nutrients become atrophied and exhibit downregulated glut1 and a 
reduction in ATP and mitochondrial potential, which suggests that atrophy results 
from depletion of metabolic substrates (Rathmell et al. 2000).  Examined from another 
perspective, kinetic inhibition of glycolysis via prevention of lactate transportation 
inhibits lymphocyte activation.  Without monocarboxylate transporter function, 
aerobic glycolysis cannot proceed because of accumulation of lactate and protons 
inside the cell (Murray et al. 2005). 
 
These studies show that metabolism, nutrient availability and activation are intimately 
intertwined.  Our research will examine how glucose metabolism can be regulated 






Antibodies and reagents 
 
Anti-CD3 (mAb 145-2C11), anti-CD28 (mAb 37.51), control hamster IgG, and PE-
labeled anti-Thy1.2,  antibodies were purchased from eBioscience (San Diego, CA).   
Anti-PLCγ and anti-phospho-PLCγ (Y783) antibodies were from Cell Signaling 
Technology (Danvers, MA).  HRP-conjugated anti-mouse IgG and anti-rabbit IgG 
were from Bio-Rad (Richmond, CA).  ERK inhibitor (U0126) and JNK inhibitor 
(SP600125) and p38 inhibitor(SB203580) were purchased from BIOMOL 




C57BL/6J mice (6-8 weeks old) were purchased from The Jackson laboratory (Bar 
Harbor, ME). All mice were maintained in ventilated M.I.C.E. microisolator cages 
(Animal Care Systems, Littleton, CO) in the University of Maryland animal facility 
(College Park, MD). Animals received humane care in compliance with the National 





T cell purification 
 
For uptake, glycolysis, FLOW, Thymidine Incorporation and Western assays, murine 
T cells were purified from lymph nodes and spleens using the Dynal Mouse T Cell 
Negative Isolation Kit (Invitrogen Corporation, Carlsbad, CA, USA) according to 
manufacturer’s protocol and as previously described.  Purified T cells were >95% 




All cells were maintained in RPMI1640 medium (Mediatech, Herndon, VA) 
supplemented with 10% FBS (Hyclone, Logan UT), 200µM glutamine, 
penicillin/streptomycin, 10mM HEPES buffer, MEM non-essential amino acids, and 
55µM 2-mercaptoethanol at 37 degrees Celsius in a 5% CO2 atmosphere.  
 
For all experiments, T cells from C57BL/6 mouse spleens and lymph nodes were 
enriched using a negative purification procedure, then stimulated for 24 hours in 
complete RPMI culture media using beads to provide stimulated and nonstimulated 
conditions.  Cells were harvested at 24 hours, mixed with Trypan Blue and counted to 







Dynalbeads M-450 Tosylactivated were prepared according to manufacturer's 
instructions.  Beads were coated with 75µg/mL anti-CD3e and 75µg/mL anti-CD28 
(stimulating condition) or 75µg/mL anti-Syrian hamster IgG and 75µg/mL anti-
Armenian hamster IgG (75µL from a 1mg/mL stock).  Beads were washed after 
incubating to adhere the antibodies, then stored in buffer with 0.02% sodium azide.  
Beads were washed twice with PBS before any cell culture experiments to rid them of 
the sodium azide.  Final concentration of beads is  4x10
7
 beads/mL, and beads are 




Proliferation after three days after stimulation in vitro was determined by [
3
H] 
thymidine incorporation. Cells were pulsed for 6-8h with 1 µCi/well of [3H] 
thymidine (MP Biomedicals, Solon, OH), transferred to glass fiber filters with a 96-
well cell harvester (Tomtec, Hamden, CT), and analyzed by liquid scintillation using a 







T cell stimulation 
 
T cells were stimulated with anti-CD3 and anti-CD28 antibody-coated beads. Briefly, 
1x10
6 
cells/mL samples were incubated with anti-CD3, anti-CD28 beads, at a ratio of 
3 beads per cell, in complete RPMI1640 medium at 37 degrees Celsius for 24 hours.  
For Krebs Cycle and pentose phosphate pathway experiments only, 10x10
6
 cells/mL 
samples were used.  For the MAP kinase inhibition assays, cells were incubated with 
2.6µM ERK inhibitor (U0126), or 50µM JNK inhibitor (SP600125), or 20µM p38 
inhibitor (SB203580) along with anti-CD3 and anti-CD28 antibody-coated beads. The 
inhibitors were also added to the complete RPMI medium during glucose uptake and 
glycolysis assay incubations.  The concentrations used for these pharmacological 
inhibitors were obtained by titration experiments to look for functional inhibition 
(JNK inhibitor, ERK inhibitor, data not shown) or from established protocols (p38 
inhibitor, ERK inhibitor).  All inhibitors were dissolved at 1000x in DMSO and mixed 




The T cells were stimulated as above and lysed in RIPA buffer (1% NP-40, 0.5% 
sodium deoxycholate,0.1% SDS, 10mM NaF, 1mM Na3VO4 in PBS)  The lysates 
were resolved on a 12% SDS PAGE gel (~1.25 x10
6
 cells/sample) and transferred 
onto nitrocellulose membrane. The blots were blocked with 5% non-fat dry milk in 




followed by HRP conjugated anti rabbit and anti mouse IgG respectively. The bands 
were visualized with SuperSignal West Pico Chemiluminescent substrate (Pierce).  
 
Beads for Stimulating and Nonstimulating Conditions 
 
For all experiments, T cells from C57BL/6 mouse spleens and lymph nodes were 
enriched using a negative purification procedure, then stimulating for 24 hours in 
RPMI culture media using beads to provide stimulated and nonstimulated conditions.  
Dynalbeads® M-450 Tosylactivated were (a) coated with 7.5µg/mL hamster anti-
mouse CD3e and 7.5µg/mL anti-mouse CD28 ("stimulated" condition) or (b) coated 
with isotype-equivalent 7.5µg/mL Armenian hamster anti-TNP IgG and 7.5µg/mL 
Syrian hamster anti-TNP IgG ("nonstimulated" condition). 
 
Glucose Uptake Assay 
 
The rate of glucose uptake was measured by assaying uptake of radioactive 1,2[
3
H]-2-
deoxyglucose (2-DOG) – a glucose analog that is not degraded – in stimulated and 




 cells for each 
sample in the triplicate) were washed with PBS, incubated for 15 minutes at 37 
degrees Celsius in glucose-free RPMI to clear the cytoplasm of glucose, then 
incubated for 10 minutes in glucose-free RPMI plus radiolabeled 2-DOG.  500µL 







Figure 5.  Glucose uptake assay illustration.  Acid sucrose, bromododecane and 
RPMI with radioactive 2-DOG (inset) are layered in a centrifuge tube.  Cells are 
added and allowed to take up 2-DOG, then are spun into the acid sucrose to stop the 
reaction.  The whole tube is frozen in a dry ice bath and the cell fraction is clipped off 













sucrose in each tube, then layering 200µL bromododecane on top.  An aliquot of cells 
in the 2-DOG mixture was carefully loaded on top of the bromododecane.  The no-cell 




 beads for each sample in the triplicate).   
 
Tubes were spun in a microcentrifuge for 1 minute to pellet cells in the lower acid-
sucrose layer.  Tubes were placed in a solid CO2/ethanol bath to freeze solid, then the 
acid-sucrose layer was clipped off into a scintillation tube and relative glucose uptake 




The hexokinase  assay is based upon the reduction of NADP+ through a coupled 
reaction with glucose-6-phosphate dehydrogenase and is measured 
spectrophotometrically by detecting the rate of increase in absorbance at 340nm..  D-
glucose + ATP in the presence of hexokinase yields glucose-6-phosphate + ADP.  
Then glucose-6-phosphate + NADP in the presence of glucose-6-phosphate 
dehydrogenase (G6PDH) yields gluconate-6-phosphate + NADPH.  NADPH absorbs 
light at 340nm while NADP does not.  Assay mix was made with 5.45g tris base, 
7.4mL 1M MgCl2, 0.666g glucose and adjusted to pH 8.5 with concentrated HCl.  Per 
100mL assay mix, 0.4mL 2.78 M thioglycerol (stored at -20 degrees Celsius) was 
added to each bottle immediately before use.  Live T cells were counted and 10x10
6
 
cells aliquoted into microfuge tubes, centrifuged at 8000 rpm for 2 minutes, and the 




minutes, then spun at 13,000 rpm at 4 degrees Celsius for 15 minutes, then lysate was 
moved to a new tube.  The reaction mix was made with 90µL Assay Mix + 
thioglycerol, 1µL NADP (50mg/mL in 0.1M NaPhos, pH 7.0), 1µL G6PDH (100 
units/mL in 0.02 M Tris with 0.2% BSA, pH 7.5), 3µL ATP (220 mM, pH 7.0).  
Assay mix and 5µL of each lysate were combined in UV transparent plates as quickly 
as possible prior to putting onto plate reader.  The rate of change of OD at 340nm was 
measured using the basic kinetic protocol on the optical plate reader at room 
temperature every 30 seconds for 10 minutes.  The change in absorbance per minute 
was determined only from the initial, linear portion of the curve.  The initial slope was 




This assay measures glycolysis rate by detecting the generation of tritiated H2O from 
5-[
3
H]-glucose during the dehydration reaction mediated by enolase [Fig. 6].  The 
tritiated water is separated from the remaining radioactive glucose by a diffusion step, 
and the rate is calculated from the ratio of diffused to undiffused radioactivity.  Fresh 
incomplete glucose-free RPMI was made, containing Q, P/S, Hepes, Amino Acids, 
and BME.  Serum was not added.  Live T cells were counted, then 1x10
6
 collected 
and washed with PBS, incubated for 15 minutes at 37 degrees Celsius in 0.5mL 
glucose-free RPMI to clear the cytoplasm of glucose.  Make up 0.5 mL glycolysis 
reaction per sample + 0.5mL for negative control.  1M glucose (dissolved in RPMI) 






Figure 6.  Glycolysis assay illustration.  Cells are incubated with radioactive glucose 
(inset) for one hour, then reaction is stopped by the addition of acid.  In a closed 
scintillation vial, radioactive water diffuses into an aliquot of distilled water while 
radioactive glucose remains inside the smaller tube.  After 2 days, the reaction tube 
and the aliquot of distilled water are read separately on a scintillation counter and 











(25mM if DMEM was used to culture T cells), then just before the end of the 15 
minute preincubation, 20µCi (20µl of 1mCi/mL stock) of radioactive glucose was 
added per mL of diluted glucose-Krebs (10µl/sample).  Cells were pelleted and 
supernatant decanted, then cells were resuspended in 0.5mL of the radioactive 
glucose-RPMI mix.  Cells were transfered to a 24-well plate and incubated at 37 
degrees Celsius in a 5% CO2 incubator for exactly 1 hour.  During the incubations, 
measurement tubes were set up.  Each sample was measured in triplicate, using 3 
PCR tubes per sample, including 3 tubes for the no-cell control and 3 tubes for the 
radioactive water control.  50µL of 0.2N HCl was added to each PCR tube.  Per 
triplicate, 0.5mL non-radioactive distilled H2O was added to each of 3 scintillation 
vials.  The 1 hour incubation was stopped by pipetting cells to resuspend them, then 
aliquoting 50µL into each of three HCl-filled PCR tubes, for a final volume of 100µL 
per PCR tube.  The diffusion control was run by adding 1µCi (1µL of 1mCi/mL 
stock) of 
3
H2O to 200µL of incomplete RPMI/10mM glucose mix, then aliquoting 
50µL into triplicate PCR tubes filled with 50µL 0.2N HCl.  The PCR tubes were 
transferred into the scintillation vials, capped tightly, and sealed with parafilm.  
Diffusion to occur at room temperature until equilibrium was established, 
approximately 2 days.  A  second set of scintillation vials was set up, parallel with the 
first.  The PCR tubes were transferred to the new scintillation vials, then 0.5mL H2O 
was added to each vial.  To adjust pH, 100µL 0.1N HCl was added to each of the 
original diffusion volumes.  3mL Cytoscint was added to all tubes, mixed thoroughly, 





Calculating the glycolytic rate 
 
1.) Determine the diffusion fraction (frac{diff}). Divide the diffused 
3
H2O counts by 
undiffused counts for each triplicate of the diffusion control and average the 
triplicates. 
2.) Determine the background diffusion rate (frac{bkgd}).  Divide the diffused counts 
by undiffused counts for each triplicate of the cell-free control and average. 
3.) Calculate the sample diffusion ratios (sample{diff}; diffused counts/undiffused 
counts) for each experimental triplicate set. 
4.)The glycolytic rate, in nanomoles glucose per million cells per hour is: 
[[sample{diff} – frac{bkgd}]] divided by [[frac{diff}]] x 5000 nmol glucose if you 
used 10mM glucose in RPMI, or x 12500 nmol glucose if you used 25mM glucose in 
DMEM. 
 
Pentose Phosphate Pathway and Krebs Cycle Assays 
 
Krebs Cycle and pentose phosphate pathway activities were measured using 
14
C-





C]-glucose [Fig. 7].  Fresh complete glucose-free 
RPMI was made, containing Q, P/S, Hepes, Amino Acids, BME and 10% dialyzed, 
heat-inactivated FBS.  GF/B Whatman filter paper circles were cut in half, rolled, and 
placed in Kontes Center wells.  The stem of the center well was pushed through a 
















Figure 7.  Krebs Cycle and Pentose Phosphate Pathway assay illustration.  In a closed 
system, glucose that is radioactive on the 1 carbon (inset above) is mixed in RPMI 
and cells are allowed to metabolize it for 8 hours.  Radioactive carbon dioxide is 
given off in both Krebs Cycle and PPP, and can be 
captured on a tissue soaked with KOH.  The tissue is 
then assayed for radioactivity.  A separate reaction is 
performed with glucose that is radioactive on the 6 
carbon (right), which is released as radioactive carbon 
dioxide only in Krebs Cycle.  The amount of CO2 
given off in the Krebs Cycle and PPP can be 




were counted and 5x10
6
 cells aliquoted into microfuge tubes, centrifuged at 8000 rpm 
for 2 minutes, and the supernatant was aspirated.  Cells were washed in 1mL warm 
(37 degrees Celsius) complete glucose-free RPMI, centrifuged, the liquid aspirated, 
then finally resuspended in 0.5mL complete glucose-free RPMI plus 10% dialyzed 
FBS.  Cells were allowed to rest 15 minutes at 37 degrees Celsius to deplete internal 
glucose stores.  Two reaction solutions were made in complete glucose-free RPMI + 
10% FBS, one containing C1-glucose and one containing C6-glucose, both at a 
concentration of 1.0µCi/mL.  0.5mL of a radioactive solution was added to each 
0.5mL aliquot of T cells, for a final concentration of 0.5µCi/mL and 5x106 T cells per 
mL.  Fresh 5% KOH (0.05g/1mL) was made using 1-2 beads of KOH and distilled 
water.   100µL KOH was added to the filter paper immediately before placing the 
stopper  onto the vial.  Vials were wrapped in parafilm and incubated for 8 hours at 
37 degrees Celsius  At 8 hours, filter papers were removed to scintillation vials 














Upregulated and Directed Glucose Metabolism Occurs During T Cell Activation. 
 
It has previously been shown that stimulation increases glucose uptake and glycolysis 
in human T cells (Frauwirth et al 2000).  In order to take advantage of the many 
genetic tools available in the murine system, C57BL/6 mice were chosen for this 
study.  A survey of glucose metabolism has been performed in concanavalin A 
stimulated cells (Hume et al. 1978), but lectins work by nonspecific cross-linking of 
activation molecules.  This model uses beads coated with anti-CD3e and anti-CD28 
antibodies in order to more specifically stimulate changes in glucose metabolism.  The 
magnetic polystyrene antibody-coated beads are 4.5µm in diameter, mimicking cell 
shape and size, and so may offer a better method of stimulation than free antibodies + 
crosslinker antibodies, or antibody-coated plates.  This method is also useful to limit 
the effect of Antigen Presenting Cells on T cells - signals from cytokines are known to 
affect metabolism, and stimulation from APCs may affect different activation 
pathways. 
 
To define glucose metabolism in murine T cells, several metabolic events were 
monitored: glucose uptake, hexokinase activity, glycolysis, Krebs Cycle, and 
pentose phosphate pathway activities.  Glucose uptake is the first step in glucose 
metabolism, and its activity regulates the amount of glucose available to downstream 




Krebs Cycle activity provide energy to the cell.  The pentose phosphate pathway 
provides reducing energy as well as metabolites used in cell structures. 
 
To assay glucose uptake, glucose transfer across the cell membrane mediated by 
GLUT1 was monitored by measuring the accumulation of radioactivity of 2-DOG 
treated cells [Fig. 5].  Stimulated T cells show an upregulated rate of glucose uptake 
[Fig. 8].  Hume et al. found that lectin-stimulated lymphocytes deplete glucose from 
the medium twice as quickly as unstimulated cells do, which correlates with our 
findings. 
 
To assay glycolysis, glucose flux through this pathway was monitored by measuring 
generation and diffusion of radioactive water 
3
H2O from metabolism of D-[5-(N)-
3
H]-
glucose during the dehydration reaction mediated by enolase [Fig. 6].  Stimulated T 
cells showed a dramatically upregulated rate of glycolysis [Fig.9] measured in 
nanomoles of glucose per million cells per hour. 
 
The strong induction of glucose flux through uptake and glycolysis was confirmed.  
With baseline measurements set, we then began inhibiting signaling pathways to 



















Figure 8.  CD3/CD28 stimulation induces glucose uptake. Splenic T cells were 
stimulated for 24 hours in full-glucose RPMI with IgG or anti-CD3/anti-CD28 coated 
beads.  Cells were counted and normalized to one million cells per trial.  Three trials 
were allowed to take up tritiated glucose for 2 minutes in glucose-free RPMI.  Uptake 






































Figure 9. CD3/CD28 stimulation strongly induces glycolysis.  Splenic T cells were 
stimulated for 24 hours with IgG or anti-CD3/anti-CD28 coated beads, and glycolysis 
rates were calculated by enolase assay as determined by release of the radioactive 


















































Glucose Metabolism Responds Strongly to Signaling through the MAP Kinase ERK 
and JNK Pathways, and to a Lesser Extent through the p38 Pathway. 
 
T cell stimulation not only causes an upregulation in metabolism, but also sets into 
motion a host of other cell responses such as gene transcription and cell cycle 
induction. An important component of T cell signaling is activation of the MAP 
kinase family members ERK, JNK and p38.  These signals were chosen because they 
are known to be activated by TCR stimulation.  Glucose metabolism has been shown 
to rise when T cells are stimulated, and signaling pathways important to glucose 
metabolism need to be identified. 
 
To determine whether MAP kinase signaling contributed to control of glucose 
metabolism, MAP kinase inhibitors were added during the stimulation 
incubation period, and metabolic events were monitored.  C57BL/6 splenic and 
lymph node T cells were stimulated as before, with CD3/CD28 beads or IgG beads, 
+/- inhibitors, then cells were collected, washed and counted using Trypan Blue to 
normalize numbers of live cells per sample.  It was determined that the concentrations 
of inhibitors did not cause large amounts of cell death at 24 hours [Fig. 10] so 
differences in measurements are true reflections of differing levels of metabolism, and 
are not due to lack of viable cells.  
 
Inhibition of MAP kinases lowered glucose uptake [Fig. 11].  The ERK kinase 















Figure 10. MAP Kinase inhibitors provide viable cells at working concentrations. A 
propidium iodide assay was used to determine that inhibitor concentrations did not 
affect cell viability at 24 hours. Splenic T cells were stimulated for 24 hours in the 
following conditions: IgG beads (Nonstimulated), anti-CD3/anti-CD28 beads 
(Stimulated), Stimulated + the recommended micromolar concentration of each 
inhibitor:  2.6µM ERK inhibitor (U0126), or 50µM JNK inhibitor (SP600125), or 
20µM p38 inhibitor (SB203580).  PI uptake was determined on FACS after a 10 
minute pulse at room temperature.  One trial was run for each condition and stopped 
when 20,000 cells had been assayed.  Because some cell death in culture is normal at 

































































Figure 11.  Inhibition of ERK, JNK, and p38 pathways lowers glucose uptake. 
Splenic T cells were stimulated for 24 hours in full-glucose RPMI with IgG or anti-
CD3/anti-CD28 coated beads, +/- inhibitors: 2.6µM ERK inhibitor (U0126), or 50µM 
JNK inhibitor (SP600125), or 20µM p38 inhibitor (SB203580).  They were then 
allowed to take up tritiated glucose for 10 minutes in glucose-free RPMI.  Uptake was 


























































































levels, while the p38 inhibitor SB203580 lowered uptake to a lesser extent.  Similar 
results were seen when glycolysis [Figs. 12 A and B] was measured. 
 
With confirmation that MAP Kinase signaling played a direct role in upregulating 
glucose uptake and glycolysis, we then decided to follow glucose through downstream 
metabolic pathways in order to better define the nutritional value imparted by glucose 
during the dynamic process of activation. 
 
Preliminary Results Indicate That Glucose Flux through Hexokinase, Krebs Cycle 
and Pentose Phosphate Pathways is Upregulated During T Cell Activation. 
 
Unpublished experiments from our lab have shown that murine T cells stimulated in 
the absence of glucose fail to attain an activation state [Fig. 13].  That the activation of 
T cells requires glucose, and in fact glucose flow through uptake and glycolysis is 
upregulated during this event, indicates that this sugar plays a crucial role in providing 
energy to the cell or providing biometabolites for structures, or both.  To better 
define the role of glucose during T cell activation, we chose to examine three 
important downstream processes:  hexokinase activity, Krebs Cycle and pentose 
























Figure 12.  Inhibition of ERK, JNK and p38 pathways lowers glycolysis. Splenic T 
cells were stimulated for 24 hours in full-glucose RPMI with IgG or anti-CD3/anti-
CD28 coated beads, +/- 2.6µM U0126 (A) or +/- 50µM JNK inhibitor (SP600125), or 
20µM p38 inhibitor (SB203580) (B), and glycolysis rates were calculated by enolase 
assay as determined by release of the radioactive hydrogen on C-5 as water, measured 
































































































































Figure 13. T Cell proliferation requires glucose.  Unfractioned, RBC-depleted 
splenocytes from 2C TCR transgenic mice were stimulated for three days with titrated 
peptide in media containing dialyzed FBS and proliferation was assayed using 








































Although GLUT1 activity is important to transport glucose into cells, because the 
glucose remains uncharged it can easily interact with GLUT1 and be transported back 
out.  The most important enzyme in increasing the presence of usable glucose in the 
cell is hexokinase.  It phosphorylates glucose, which does two things.  First, it traps it 
in the cell, as GLUT1 cannot transport out a negatively charged molecule.  Second, 
adding the phosphate group turns glucose into a substrate for downstream enzymatic 
reactions such as glycolysis, pentose phosphate pathway and Krebs Cycle. 
 
Hexokinase activity data for nonstimulated versus stimulated T cells are preliminary 
and are presented to showcase a trend in glucose metabolism, while Krebs Cycle and 
pentose phosphate pathway activity data for nonstimulated versus stimulated T cells 
have been confirmed.  Fig. 14 represents one hexokinase assay in triplicate and was 
not repeated due to time constraints.  Hexokinase activity was measured by 
fluorimetric detection of NADP to NADPH conversion in stimulated and 
nonstimulated T cell lysates in triplicate.  Stimulated T cells showed upregulated 
hexokinase activity during the logarithmic phase of the assay which lasted about 2 
minutes [Fig. 14]. 
 
Krebs Cycle is primarily catabolic, providing ATP directly, and also NADH and 
FADH2 which are used by the mitochondria to make ATP.  The pentose phosphate 
pathway  is primarily anabolic, providing ribose-5-phosphate used to make DNA, 
erythrose-4-phosphate used in production of aromatic amino acids, and NADPH 















Figure 14.  Inhibition of ERK, JNK, and p38 pathways lowers hexokinase activity. 
Splenic T cells were stimulated for 24 hours in full-glucose RPMI with IgG or anti-
CD3/anti-CD28 coated beads, +/- inhibitors, then collected and assayed for 
hexokinase activity.  Enzyme activity was measured via a coupled fluorimetric 













































free radicals produced by mitochondria whose activity is also upregulated during 
activation.  The protective property of NADPH comes from its ability to return 
glutathione, an intracellular antioxidant, to its reduced state. 
 
Krebs Cycle and pentose phosphate pathway were measured using a paired assay; two 
reactions were run separately, then analyzed for evolution of radioactive carbon 
dioxide.  One reaction contained  D-[1-
14
C]-glucose which had a radioactive carbon in 
the C1 position of glucose.  This carbon is released as CO2 during both Krebs Cycle 
and Pentose Phosphate Cycle.  The second reaction contained only D-[6-
14
C]-glucose 
which had a radioactive carbon in the C6 position.  This carbon is released as CO2 
only during Krebs Cycle.  Krebs Cycle activity was determined directly from the 
count in the vial containing  D-[6-
14
C]-glucose, and pentose phosphate pathway 
activity was determined by calculating how much of the radioactivity from the D-[1-
14
C]-glucose reaction was produced during the Krebs Cycle, then subtracting that 
amount from the total radioactivity produced.  Stimulated T cells showed upregulated 
pentose phosphate pathway, but Krebs Cycle activity was not raised very much [Fig. 
15]. 
 
Because carbon flux through Krebs Cycle results in ATP production and active cells 
need more ATP, it was expected that glucose use in Krebs Cycle would increase, but 
there was little change.  This indicates that glucose is shunted away from Krebs Cycle 
during T cell activation, though the use of amino acids or other metabolites may be 















Figure 15.  CD3/CD28 stimulation induces Krebs Cycle and Pentose Phosphate 
Pathway activity.  Splenic T cells were stimulated for 24 hours with IgG or anti-
CD3/anti-CD28 coated beads, and Krebs Cycle and Pentose Phosphate Pathway rates 
were calculated by CO2-release assay as determined by release of the radioactive C-1 
or C-6 as carbon dioxide, measured via scintillation counting.  Activated T cells 









































Experiments with EL4 cells, a murine T cell lymphoma line, showed that they have an 
extremely high and  constitutively upregulated flux of glucose through the pentose 
phosphate pathway, and very little flux through Krebs Cycle [Fig. 16].  The finding 
that T cells specifically  upregulate only some of the pathways that metabolize 
glucose and the finding that cancer cells shunt glucose at a quick pace through the 
pentose phosphate pathway are strong evidence that the T cell actively and tightly 
controls how glucose is used in order to achieve a specific collection of end 
metabolites for optimal activation. 
 
Preliminary Results Indicate That Glucose Flux May Respond Strongly to Signaling 
through the MAP Kinase ERK and JNK Pathways and to a Lesser Extent through the 
p38 Pathway. 
 
Data for glucose flux through hexokinase, Krebs Cycle and pentose phosphate 
pathway measured under MAP kinase inhibition are preliminary and are presented to 
showcase a trend in glucose metabolism.   
 
Inhibition of MAP kinases lowered hexokinase activity [Fig. 14].  This assay, in 
triplicate, was performed one time.  The ERK kinase inhibitor U0126 and the JNK 
inhibitor SP600125 lowered uptake almost to resting levels, while the p38 inhibitor 
SB203580 lowered uptake to a lesser extent.  Similar results were seen when the 
pentose phosphate pathway was measured [Fig. 16].  Fig. 16 represents one assay in 















Figure 16.  Inhibition of ERK, JNK and p38 pathways lowers Pentose Phosphate 
Pathway activity.  Splenic T cells were stimulated for 24 hours with IgG or anti-
CD3/anti-CD28 coated beads, + 2.6µM ERK inhibitor (U0126), or 50µM JNK 
inhibitor (SP600125), or 20µM p38 inhibitor (SB203580).  Krebs Cycle and Pentose 
Phosphate Pathway rates were calculated by CO2-release assay as determined by 
release of the radioactive C-1 or C-6 as carbon dioxide, measured via scintillation 






































































here are very representative of what we expect to see when this assay is confirmed.  
Krebs Cycle activity was slightly affected by MAP kinase inhibition, but because 
glucose use in Krebs Cycle was only minimally raised by TCR stimulation, the effects 







It is known that glucose metabolism increases upon initiation of activation in order to 
meet the increased metabolic needs of a proliferating, metabolically active cell.  Little 
is known about the cellular control of metabolic changes that enable the cell to sustain 
its increased growth and proliferation programs.  Our hypothesis was focused to 
determine if glucose metabolism was regulated by signal transduction initiated during 
T cell activation; we tested this hypothesis by administering and modulating TCR 
stimulation.  We measured production of various metabolites of glucose and enzyme 
activity to determine which metabolic pathways were influenced by T cell stimulation.  
We then performed the same measurements while blocking specific signaling 
pathways.  Our results show that ERK and JNK pathways appear to be determining 
factors because their inhibition downregulated glucose uptake and glycolysis.  
Inhibition of another MAPK pathway (p38) causes some downregulation of these 
activities but the effect is not as strong as with the ERK and JNK inhibitors.  From 
this we can infer that the p38 pathway is less important in regulating glucose 
metabolism.  
 
Emerging evidence is showing that not only do T cells need two signals in order to 
become activated, but that they also need an upregulated and sustained metabolism in 
order to successfully complete the activation process.  Since glucose is a prime 
energy source, its use was a logical place on which to focus metabolism studies, and 




We limited our scope to MAP Kinases because these molecules are directly involved 
in T cell signaling.  The three MAP Kinase families we studied were extracellular 
signal-regulated kinases ERK1 and ERK2; c-Jun amino-terminal kinases that are 
activated by stress JNK1, JNK2 and JNK3; and p38 isoforms alpha, beta, gamma and 
delta. (Chen et al.  2001) (Kyriakis and Avruch 2001). 
 
The work presented here supports the hypothesis that metabolism is regulated directly 
via receptor-mediated signals.  This is a change from previous views that catabolic 
derepression (i.e. depletion of nutrients through metabolism) was the signal that 
changed glucose use within the cell. We first showed that upregulated glucose uptake 
and glycolysis were two responses to T Cell Receptor signaling plus CD28 co-
stimulation.  Next we blocked several downstream MAP kinase signaling pathways 
and observed differing effects on glucose metabolism.  ERK and JNK blockades were 
seen to control metabolism almost identically, while p38 blockade appeared to affect 
metabolism about half as strongly.  These results taken together show that glucose 
metabolism can be regulated with T Cell Receptor signaling plus CD28 co-
stimulation and also that blockade of this stimulation pathway results in the cell 
actively preventing changes in its glucose metabolism.  It is interesting to note that 
blocking p38 stimulation did not have as great an effect as blocking the other two 
activation pathways.  We believe this to be an important observation because other 
studies have shown that ERK and JNK behave similarly while p38 activity differs 
even though still clearly acting within the classical MAP kinase cascade.  Comparing 




greater understanding of the human kinome.  Also, that T Cell Receptor stimulation 
causes several pathways to be activated is important to note because this means that 
the cell could control each pathway separately, thereby allowing it to fine tune the 
repertoire of proteins produced.   
 
The relationships between activating signals, MAP Kinases, and the final phenotype 
of a cell (whether activated or reacting to growth factors or other extracellular 
stimuli) are not easy to predict because activation pathways are more like webs and 
scaffolds than lines.  MAPKs can be activated by many different stimuli, but in 
general, ERK1 and ERK2 are activated by growth factors and phorbol esters, while 
the JNK and p38 kinases are more responsive to stress stimuli like osmotic shock, 
radiation damage, or cytokine stimulation (Pearson et al. 2001).  All MAP Kinase 
pathways consist of a cascade of activating kinases, but substrate selectivity may be 
modulated by specific interaction motifs on the protein that is being activated. 
Furthermore, MAPK cascade specificity is also mediated through interaction with 
scaffolding proteins which organize pathways in specific modules through 
simultaneous binding of several components (Pearson et al. 2001).   These variables 
may be the cause of p38's weaker effect on changes in glucose metabolism.  Many 
different studies ranging from detection of phosphorylated molecules to protein 
associations to kinase activity measurements could be done to characterize how the 





Knowledge of MAP Kinase effects on glucose metabolism could have many practical 
applications, not the least of which include chemotherapy and immunosuppression.  
Cancers and T cells that attempt to become activated have in common that their 
metabolisms are upregulated.  Rapamycin has been shown to have anti-cancer actions 
(Guba et al. 2002), possibly because it affects glucose use within the cancer cells.  
Because cancer uses so much glucose, the environment inside a cancer mass may not 
be conducive to T cell activation.  Knowledge of the importance of glucose to T cell 
activation will increase our understanding in this area.  In addition, knowledge of T 
cell metabolism will reveal new uses for known drugs.  For example, if the Pentose 
Phosphate Pathway is highly upregulated by cancer cells, but is not upregulated in 
activated T cells, this indicates that drugs that inhibit this pathway may safely be used 
to treat the cancer.  In the same way HAART anti-retroviral therapy uses several 
chemicals to inhibit different stages of replication in HIV-infected cells, specific 
drugs that affect glucose metabolism could be combined with other drugs in order to 
shut down, modulate, or reroute nutrient metabolism in cancer cells. 
 
In order to gain insight into the conclusions of this study, there are several important 
questions one could answer.  Changes in glucose metabolism in human T cells are 
detectable within 6 hours of stimulation (Frauwirth et al. 2002), before cell cycle entry 
or growth begin.  It has been suggested that T cells "survey" the environment (by 
detecting levels of metabolites, ATP, or nutrients) before they begin to proliferate in 




determine the cause-and-effect relationship between activation signals and metabolic 
signals it is necessary to dissect the pathways from start to finish. 
 
To determine initial responses to stimulation in the absence of glucose, T cells could 
be stimulated in the presence or absence of glucose, and activation state of MAP 
Kinases assessed.  One could also check proliferation, IL-2 production, and various 
surface activation markers such as CD25, and CD44 to see if other hallmarks of T cell 
activation are affected by glucose deprivation during a stimulation signal.  
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